Connect with us


Digital Diagnostics Moves Beyond Just Eyecare with Acquisition of 3Derm Systems

The company’s flagship product system diagnoses diabetic retinopathy and diabetic macular edema.




CORALVILLE, IA — Digital Diagnostics Inc., a global healthcare autonomous artificial intelligence company formerly known as IDx, has acquired 3Derm Systems Inc. of Boston.

The rebrand of IDx to Digital Diagnostics reflects its expanded platform of autonomous AI products in multiple medical specialties. The company’s flagship product, IDx-DR, “was the first autonomous AI system De Novo authorized by the FDA in any field of medicine,” according to a press release announcing the deal. The system diagnoses diabetic retinopathy and diabetic macular edema.

MasterClass: Redefining Retail as Slow Retail

MasterClass: Redefining Retail as Slow Retail

2024 Digital Trends
4ECPs Webinars

2024 Digital Trends

Leadership, Empathy, and a Noble Cause

Leadership, Empathy, and a Noble Cause

With the acquisition of 3Derm, the Digital Diagnostics platform will include telemedicine capabilities for dermatology, 3DermTriage, in preparation for FDA authorization of its autonomous AI skin cancer diagnostic system, 3DermSpot.

Financial terms of the transaction were not disclosed.

In “autonomous AI, “it is the computer, not the clinician, making the medical decisions, enabling patients to obtain diagnoses for serious conditions when and where they receive medical care.” according to the release.


“There is too much needless suffering from treatable illnesses, and this happens more in populations that do not have equitable access to healthcare, and particularly to specialist physicians,” said Michael Abramoff, MD, PhD, founder and executive chairman of Digital Diagnostics. “Our autonomous systems allow frontline care providers to instantaneously diagnose serious conditions, refer patients who need specialist treatment faster, and improve long-term patient outcomes.”

Digital Diagnostics was founded in 2010 by Abramoff, a practicing, fellowship-trained retina specialist ophthalmologist, neuroscientist and computer engineer who developed a patented biomarker-based approach to build AI algorithms that perform cognitively complex tasks.

To make instantaneous diagnoses, both IDx-DR and 3DermSpot use high quality images of the eyes and skin coupled with autonomous AI; the system is operated by existing primary care clinic staff.

Digital Diagnostics products “are in use by the largest and most prestigious health systems in the U.S. and globally,” according to the release.

“By using Digital Diagnostics’ autonomous AI platform, 3DermSpot decreases the time it takes to put their life saving device in the hands of frontline care providers,” said John Bertrand, CEO, Digital Diagnostics. “Expanding the specialties our products cover allows our customers to use our platform as their one stop shop for autonomous AI diagnostics at the point-of-care.”




The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines






Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular